Interline Therapeutics logo — We are leveraging advances in genomics, proteomics and compu...

Interline Therapeutics

We are leveraging advances in genomics, proteomics and computational chemistry to identify new medicines

Founded 2020 United States Brisbane, United States 2 employees Seed Total: $59.50M Biotechnology

General Information

Company Name Interline Therapeutics
Founded Year 2020
Location United States Brisbane, United States
Employees 2
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Interline Therapeutics. To contact Interline Therapeutics, visit interlinetx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Interline Therapeutics compare?

A PDF of Interline Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Interline Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Interline Therapeutics

Interline Therapeutics is a drug discovery company focused on systematically elucidating protein communities to define molecular mechanisms of disease. Based on these insights, we are discovering new medicines to treat cancer and inflammatory diseases. Interline is headquartered in Brisbane, CA.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $59.50M 2
Arch Venture Partners, Foresite Capital
01 May 2021

Interline Therapeutics Alternatives & Competitors

View All Alternatives
Interline Therapeutics vs
Wren Therapeutics
Wren Therapeutics United Kingdom

Stopping the wave of neurodegeneration at its source

Venture round
34 employees
Biopharma, Biotechnology
Interline Therapeutics vs

Pioneering novel molecular approaches for the treatment of metabolic, inflammatory, and fibrotic dis...

Seed
3 employees
Biotechnology, Health Care
Interline Therapeutics vs
Cairn Biosciences
Cairn Biosciences United States

Navigating exclusive paths to new medicines

Grant
5 employees
Biotechnology, Health Care

FAQ About Interline Therapeutics

We are leveraging advances in genomics, proteomics and computational chemistry to identify new medicines
Interline Therapeutics was founded in 2020.
Interline Therapeutics is headquartered in Brisbane, United States.
Interline Therapeutics operates in Biotechnology.
Interline Therapeutics has approximately 2 employees.
Interline Therapeutics has completed 1 funding round, raising a total of $59.50M. The latest funding stage is Seed.
Top alternatives and competitors to Interline Therapeutics include Wren Therapeutics, Elgia Therapeutics, Inc., Cairn Biosciences, Harmonic Discovery, Halda Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Interline Therapeutics and Wren Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Interline Therapeutics, https://bouncewatch.com/company/interline-therapeutics, updated 30 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes